• Rafael announces continuation of Phase 3 TransportNPC study following DMC review TipRanks Wed, 18 Jun 2025 11:13:10 GMT
• Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Ind... The Manila Times Wed, 18 Jun 2025 07:00:00 GMT
• rafael holdings reports improved financial results and strategic progress TipRanks Thu, 12 Jun 2025 03:58:25 GMT
• Rafael Holdings Slashes Losses 85% as Crucial Phase 3 Rare Disease Trial Results Loom Stock Titan Wed, 11 Jun 2025 07:00:00 GMT
• Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results The Manila Times Wed, 11 Jun 2025 07:00:00 GMT
• gsk taps sanofi vet to lead vaccine r&d; bristol myers names head of corporate affairs Endpoints News Fri, 06 Jun 2025 07:00:00 GMT
• rafael holdings announces final results and closing of rights offering MarketScreener Wed, 04 Jun 2025 20:12:45 GMT
• rafael ceo backs $25m rights offering to fund critical phase 3 rare disease drug trial Stock Titan Wed, 04 Jun 2025 20:01:00 GMT
• niemann-pick disease type c market to expand significantly openPR.com Fri, 23 May 2025 07:00:00 GMT
• Zevra Cashes in on First FDA-Approved NPC Treatment with PRV Genetic Engineering and Biotechnology News Thu, 22 May 2025 07:00:00 GMT
• rfl stock touches 52-week low at $1.28 amid market challenges by investing.com Investing.com India Wed, 21 May 2025 14:28:20 GMT
• rafael holdings, inc. provides update to the description of subscription rights related to its public warrants in connection with ... The Manila Times Wed, 21 May 2025 07:00:00 GMT
• rafael holdings rights offering: $25m deal terms revealed, may 29 deadline approaches Stock Titan Tue, 20 May 2025 07:00:00 GMT
• rafael holdings, inc. provides update to the description of subscription rights related to its public warrants in connection with ... The Globe and Mail Tue, 20 May 2025 07:00:00 GMT
• azafaros secures 132 million euros in series b financing The Pharma Letter Wed, 14 May 2025 09:54:54 GMT
• rafael holdings reports first quarter fiscal 2025 financial results ADVFN Mon, 05 May 2025 20:25:33 GMT
• Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offerin... The Manila Times Mon, 05 May 2025 07:00:00 GMT
• rafael holdings launches $25m rights offering: key dates and terms investors must know Stock Titan Mon, 05 May 2025 07:00:00 GMT
• Rafael Holdings Secures Future: $25M Rights Offering Powers Critical Phase 3 Drug Launch Plans Stock Titan Tue, 29 Apr 2025 07:00:00 GMT
• rafael holdings, inc. announces proposed terms of a $25 million rights offering to support its commitment to the development and p... The Globe and Mail Tue, 29 Apr 2025 07:00:00 GMT
• cyclo therapeutics (nasdaq:cyth) and genfit (nasdaq:gnft) financial comparison Defense World Sat, 26 Apr 2025 07:00:00 GMT
• rafael holdings strengthens its focus on the development of trappsol® cyclo™ and announces chief executive officer bill conkling w... The Manila Times Fri, 25 Apr 2025 07:00:00 GMT
• Rafael Holdings Announces Leadership Transition Following Merger with Cyclo Therapeutics and Full Enrollment of TransportNPC™ Phas... Nasdaq Thu, 24 Apr 2025 07:00:00 GMT
• rafael holdings pivots to breakthrough rare disease drug development as leadership changes Stock Titan Thu, 24 Apr 2025 07:00:00 GMT
• rafael holdings strengthens its focus on the development of trappsol® cyclo™ and announces ... Bluefield Daily Telegraph Thu, 24 Apr 2025 07:00:00 GMT
• contrasting biontech (nasdaq:bntx) and cyclo therapeutics (nasdaq:cyth) Defense World Thu, 03 Apr 2025 07:00:00 GMT
• rafael holdings finalizes merger with cyclo therapeutics by investing.com Investing.com South Africa Thu, 27 Mar 2025 00:24:19 GMT
• Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals GlobeNewswire Wed, 26 Mar 2025 07:00:00 GMT
• Major Pharma Merger: Rafael Holdings Gains Phase 3 Rare Disease Asset in Strategic Deal Stock Titan Wed, 26 Mar 2025 07:00:00 GMT
• Rafael Holdings finalizes merger with Cyclo Therapeutics Investing.com Wed, 26 Mar 2025 07:00:00 GMT
• watch: rondina leads choco mucho into pvl all filipino semis The Manila Times Wed, 26 Mar 2025 07:00:00 GMT
• Rafael Holdings secures shareholder nod for Cyclo Therapeutics merger Investing.com Tue, 25 Mar 2025 07:00:00 GMT
• cyclo therapeutics shareholders approve merger with rafael holdings by investing.com Investing.com India Tue, 25 Mar 2025 07:00:00 GMT
• cyclo therapeutics shareholders approve merger with rafael holdings Investing.com Mon, 24 Mar 2025 07:00:00 GMT
• william shanahan obituary (2025) - new york, ny - new york times Legacy.com Sun, 23 Mar 2025 07:00:00 GMT
• 12 health care stocks moving in thursday's after-market session Benzinga Thu, 20 Mar 2025 21:06:20 GMT
• march madness: flutter stock is a solid bet on sustained growth The Globe and Mail Thu, 20 Mar 2025 11:51:00 GMT
• cyclo therapeutics announces allowance of patent application for treatment of alzheimer’s disease from the u.s. patent and tradema... Business Wire Thu, 20 Mar 2025 06:30:36 GMT
• q4 earnings highlights: apogee (nasdaq:apog) vs the rest of the commercial building products stocks The Globe and Mail Tue, 18 Mar 2025 07:00:00 GMT
• cyclo therapeutics announces closing of strategic investment through a $2.1 million private placement from rafael holdings, inc. (... Business Wire Mon, 17 Mar 2025 19:45:01 GMT
• cyclo therapeutics earnings preview: recent $cyth insider trading, hedge fund activity, and more Nasdaq Sat, 15 Mar 2025 07:00:00 GMT
• rafael holdings inc reports q2 2025 earnings: eps at -$0.19, str GuruFocus.com Fri, 14 Mar 2025 10:35:57 GMT
• rafael holdings reports second quarter fiscal 2025 financial results The Manila Times Fri, 14 Mar 2025 07:00:00 GMT
• rafael holdings swings to $4.6m loss as cyclo therapeutics merger approaches StockTitan Thu, 13 Mar 2025 21:50:00 GMT
• Rafael Holdings, Inc. Reports Financial Results and Anticipates Closure of Merger with Cyclo Therapeutics in Q3 Nasdaq Thu, 13 Mar 2025 07:00:00 GMT
• rafael holdings reports second quarter fiscal 2025 financial results TradingView Thu, 13 Mar 2025 07:00:00 GMT
• cyclo therapeutics (cyth) to release quarterly earnings on monday Defense World Mon, 10 Mar 2025 07:00:00 GMT
• cyclo therapeutics secures $2.5 million in funding by investing.com Investing.com Australia Fri, 07 Mar 2025 17:21:18 GMT
• Is Cyclo Therapeutics, Inc. (CYTH) the Best Micro Cap Stock to Buy Now? Yahoo Finance Fri, 07 Mar 2025 08:00:00 GMT
• william shanahan obituary (2025) - stamford, ct - the advocate Legacy.com Fri, 07 Mar 2025 08:00:00 GMT
• cyclo therapeutics inc issues $2.5 million convertible promissory note to rafael holdings Marketscreener.com Thu, 06 Mar 2025 17:40:25 GMT
• emerging market etfs: a shield against trump’s tariff threats? The Globe and Mail Fri, 28 Feb 2025 08:00:00 GMT
• is weride stock a buy, sell, or hold as nvidia reveals its $25 million bet? The Globe and Mail Sun, 23 Feb 2025 15:23:22 GMT
• shareholder investigation: halper sadeh llc investigates blue, voxx, cara, cyth on behalf of shareholders PR Newswire Fri, 21 Feb 2025 08:00:00 GMT
• CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo... Business Wire Thu, 20 Feb 2025 08:00:00 GMT
• niemann-pick disease type c market expected to exhibit a cagr of 17.05% during 2025-2035, impelled by rising awareness and early d... BioSpace Wed, 19 Feb 2025 08:00:00 GMT
• 3 stocks to hedge against inflation’s persistence The Globe and Mail Mon, 17 Feb 2025 12:22:30 GMT
• allegion (alle) q4 earnings report preview: what to look for The Globe and Mail Mon, 17 Feb 2025 08:00:00 GMT
• cyclo therapeutics extends merger agreement with rafael holdings MSN Sat, 15 Feb 2025 08:00:00 GMT
• supercom (nasdaq: spcb) expands presence with advanced em project in latvia The Globe and Mail Thu, 13 Feb 2025 08:00:00 GMT
• cyclo therapeutics logs efficacy win in pivotal niemann-pick disease trial MSN Wed, 12 Feb 2025 21:24:32 GMT
• reviewing cyclo therapeutics (nasdaq:cyth) and vitro diagnostics (otcmkts:vodg) Defense World Wed, 12 Feb 2025 08:00:00 GMT
• fda approves mirdametinib for patients 2 years, older with neurofibromatosis type 1 Contemporary Pediatrics Tue, 11 Feb 2025 21:50:12 GMT
• atypical presentations of mycoplasma pneumoniae amid a local outbreak Contemporary Pediatrics Tue, 11 Feb 2025 19:12:39 GMT
• cyclo therapeutics inc (cyth) stock: a year of market movement, down and up The InvestChronicle Tue, 11 Feb 2025 17:40:36 GMT
• adversity is less terrifying than hope: cyclo therapeutics inc (cyth) SETE News Tue, 11 Feb 2025 15:24:30 GMT
• cyclo therapeutics logs efficacy win in pivotal niemann-pick disease trial Clinical Trials Arena Tue, 11 Feb 2025 11:15:00 GMT
• 12 health care stocks moving in monday's pre-market session Benzinga India Tue, 11 Feb 2025 08:00:00 GMT
• conduit, mgo global, and cyclo therapeutics: penny stocks to watch this week PUNE.NEWS Tue, 11 Feb 2025 08:00:00 GMT
• rafael holdings extends merger agreement deadline by investing.com Investing.com Nigeria Tue, 11 Feb 2025 07:50:13 GMT
• will cyclo therapeutics inc (cyth) meet earnings estimates this quarter? US Post News Mon, 10 Feb 2025 19:11:05 GMT
• fda grants rezpegaldesleukin fast track to treat moderate, severe atopic dermatitis Contemporary Pediatrics Mon, 10 Feb 2025 16:58:48 GMT
• cyclo therapeutics logs efficacy win in pivotal niemann-pick disease trial Clinical Trials Arena Mon, 10 Feb 2025 08:00:00 GMT
• weekly review: new delgocitinib data for eczema, fda action items, more Contemporary Pediatrics Mon, 10 Feb 2025 08:00:00 GMT
• 12 health care stocks moving in monday's pre-market session Benzinga Mon, 10 Feb 2025 08:00:00 GMT
• prediction: these 2 vanguard etfs will trounce the s&p 500 this year The Globe and Mail Mon, 10 Feb 2025 08:00:00 GMT
• cyclo therapeutics inc’s: contrasting stock performances in a volatile market The InvestChronicle Fri, 07 Feb 2025 20:53:08 GMT
• solid power inc (sldp) stock: a year of market movement, down and up The InvestChronicle Fri, 07 Feb 2025 20:53:08 GMT
• educating your patients about the dangers of frostbite Contemporary Pediatrics Fri, 07 Feb 2025 20:41:14 GMT
• is lipella pharmaceuticals inc (nasdaq:lipo) stock a better investment at this time? US Post News Fri, 07 Feb 2025 18:03:03 GMT
• cyclo therapeutics inc (nasdaq:cyth) stock: you might be surprised US Post News Fri, 07 Feb 2025 18:02:54 GMT
• analyzing the price-to-earnings ratio of cyclo therapeutics inc (cyth) The News Heater Fri, 07 Feb 2025 17:08:08 GMT
• aep’s stock market pendulum: swinging between gains and losses The InvestChronicle Fri, 07 Feb 2025 14:54:39 GMT
• ouster inc’s bumpy road: analyzing the 52-week range and future prospects The InvestChronicle Fri, 07 Feb 2025 14:54:39 GMT
• fnb’s market quandary: decoding the ups and downs of 2023 The InvestChronicle Fri, 07 Feb 2025 14:54:39 GMT
• juniper networks inc (jnpr) presents a great opportunity, but the stock is slightly undervalued US Post News Fri, 07 Feb 2025 12:04:31 GMT
• Breakthrough NPC1 Treatment Data: 87% of Young Patients Show Recovery Signs in Cyclo Trial Stock Titan Fri, 07 Feb 2025 08:00:00 GMT
• Positive data reported for Trappsol Cyclo in patients 3 years and under with NPC1 contemporarypediatrics.com Fri, 07 Feb 2025 08:00:00 GMT
• Cyclo Therapeutics reports promising NPC1 treatment findings Investing.com Fri, 07 Feb 2025 08:00:00 GMT
• cyclo therapeutics presents positive data from phase 3 npc1 sub-study Nasdaq Fri, 07 Feb 2025 08:00:00 GMT
• cyclo therapeutics: strategic shifts trigger excitement timothysykes.com Fri, 07 Feb 2025 08:00:00 GMT
• 12 health care stocks moving in friday's pre-market session Benzinga Fri, 07 Feb 2025 08:00:00 GMT
• stock market today: garden stage skyrocketed by 126.15% while nikola corporation plunged by 40.19% in early trading Business Upturn Fri, 07 Feb 2025 08:00:00 GMT
• cyclo therapeutics presents positive preliminary data from ongoing phase 3 transportnpc(tm) open-label sub-study in patients ( Marketscreener.com Fri, 07 Feb 2025 08:00:00 GMT
• cyclo therapeutics extends merger agreement with rafael holdings by investing.com Investing.com South Africa Wed, 05 Feb 2025 04:38:35 GMT
• cyclo therapeutics extends merger agreement with rafael holdings Investing.com Tue, 04 Feb 2025 08:00:00 GMT
• quantum genomics société anonyme (otcmkts:qnntf) versus cyclo therapeutics (nasdaq:cyth) head-to-head contrast Defense World Thu, 30 Jan 2025 08:00:00 GMT
• advances in cyclotide research: bioactivity to cyclotide-based therapeutics | request pdf ResearchGate Wed, 29 Jan 2025 08:00:00 GMT
• shareholder notice: halper sadeh llc investigates wmpn, alvr, cyth on behalf of shareholders Finansavisen Tue, 28 Jan 2025 08:00:00 GMT
• shareholder investigation: halper sadeh llc investigates atsg, cyth, alvr on behalf of shareholders The Malaysian Reserve Fri, 24 Jan 2025 08:00:00 GMT
• shareholder investigation: halper sadeh llc investigates atsg, cyth, alvr on behalf of shareholders PR Newswire Thu, 23 Jan 2025 08:00:00 GMT
• if lokayukta gives clean chit to cm siddaramaiah in muda case we will fight it: karnataka bjp PUNE.NEWS Thu, 23 Jan 2025 08:00:00 GMT
• $hareholder alert: the m&a class action firm continues to investigate the merger - cyth, alvr, wmpn, omc The Malaysian Reserve Thu, 23 Jan 2025 02:20:46 GMT
• $hareholder alert: the m&a class action firm continues to investigate the merger - cyth, alvr, wmpn, omc Finansavisen Wed, 22 Jan 2025 08:00:00 GMT
• niemann-pick disease type c therapeutics market size was ~usd 34 million in 2022 and is anticipated to grow with a significant cag... Barchart Tue, 21 Jan 2025 00:18:26 GMT
• niemann-pick disease type c therapeutics market size was ~usd 34 openPR Mon, 20 Jan 2025 22:18:00 GMT
• cyclo therapeutics faces potential delisting due to failure to hold annual shareholders meetingunited states securities and exchan... Defense World Wed, 15 Jan 2025 07:15:23 GMT
• rafael holdings reports favorable shareholder votes Investing.com India Tue, 14 Jan 2025 23:03:22 GMT
• cyclo therapeutics to present groundbreaking trappsol® cyclo™ research at worldsymposium 2025 Stock Titan Tue, 14 Jan 2025 08:00:00 GMT
• cyclo therapeutics faces nasdaq delisting over meeting lapse Investing.com Mon, 13 Jan 2025 08:00:00 GMT
• great news or bad news? cyclo therapeutics faces critical crossroads! Jomfruland.net Mon, 13 Jan 2025 08:00:00 GMT
• amrn stock rises over 5% amidst lack of institutional ratings GuruFocus.com Tue, 07 Jan 2025 08:00:00 GMT
• cyclo therapeutics, inc. announced that it has received $1 million in funding Marketscreener.com Mon, 06 Jan 2025 13:56:21 GMT
• cyclo therapeutics enters into significant note purchase agreement with rafael holdings Defense World Sun, 05 Jan 2025 08:00:00 GMT
• cyclo therapeutics inks $3m convertible note with rafael holdings Investing.com Sat, 04 Jan 2025 03:28:12 GMT
• cyclo therapeutics inks $3m convertible note with rafael holdings by investing.com Investing.com UK Fri, 03 Jan 2025 21:04:00 GMT
• cyth stock touches 52-week low at $0.57 amid market challenges Investing.com Australia Wed, 01 Jan 2025 04:31:56 GMT
Cyclo Therapeutics, Inc(NASDAQ:CYTH) 
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. The company's lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. It also sells cyclodextrins and related ...
Website: https://www.cyclotherapeutics.com/
Founded: 1990
CEO: Scott Fine
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Share this website to your friends